Correlation Engine 2.0
Clear Search sequence regions

  • africa (1)
  • antivenins (8)
  • antivenins (2)
  • health facilities (4)
  • humans (1)
  • medicines (1)
  • snake (1)
  • zambia (2)
  • Sizes of these terms reflect their relevance to your search.

    Despite snakebite antivenom being included on the WHO list of essential medicines, many parts of the world, especially Africa, lack effective and safe antivenoms. A descriptive, field-based, cross-sectional study was undertaken from August to November 2020 in 40 out of 71 health facilities in Ndola district. Interviews and physical inspection were conducted at each facility. The study revealed that only three (8%) of all the private health facilities had antivenom available at the time of the assessment. Factors significantly associated with antivenom supply included lack of central country supply (90%), lack of demand of the antivenom (55%) and no budget allocation for the antivenom (95%). Despite the high number of notified snakebites within Ndola district, there remains poor availability of snakebite antivenom within the district. © The Author(s) 2021. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.


    Scott K Matafwali, Pipina A Vlahakis, Victor Daka, Bwalya A Witika, Herbert T Nyirenda, Namaunga K Chisompola, Chiluba Mwila. Assessment of the availability of snakebite antivenom in health facilities in Ndola District, Zambia: a cross-sectional study. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2022 Jun 01;116(6):592-594

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 34850233

    View Full Text